The global cognitive computing and artificial intelligence systems market in healthcare is undergoing rapid structural expansion, driven by demand for AI-enabled diagnostics, clinical decision support, patient monitoring and pharmaceutical research. BCC Research projects the deep-learning segment to grow at approximately a 36.1% CAGR over the forecast period. North America and Europe each held a 27.4% regional share in 2024, while Asia-Pacific remains positioned for rapid future growth. Adoption is being accelerated by chronic disease, aging populations, imaging workloads, shortages of radiologists and pathologists, cloud infrastructure and public digital-health programs. China’s healthcare AI market is projected to rise from $0.55 billion in 2022 to more than $11.9 billion by 2030 at a 47% CAGR, while Japan’s market is projected to reach $1.87 billion by 2030 at a 21.7% CAGR. Competitive activity spans hyperscalers, healthcare technology companies, medical-device makers and specialized AI vendors, with emerging applications including generative AI, large language models, digital pathology, genomics and edge computing. Investment opportunities are accompanied by risks involving regulation, explainability, reimbursement, data privacy, interoperability and infrastructure.